Marsh & McLennan downgraded to Neutral from Outperform at Credit Suisse Credit Suisse downgraded Marsh & McLennan to reflect its high exposure to property & casualty insurance brokerage platform vs. higher revenue healthcare exchange revenues. Price target raised to $53 from $48.
News For MMC From The Last 14 Days
Check below for free stories on MMC the last two weeks.
Mercer acquires Transition Assist, terms not disclosed Mercer, a subsidiary of Marsh & McLennan Companies, has reached a definitive agreement to purchase Transition Assist, a retiree exchange specializing in helping retirees in employer-sponsored plans select Medicare supplemental health care insurance. Terms of the transaction were not disclosed.